Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126791772 | 12679177 | 2 | F | 20160713 | 20160824 | 20160909 | PER | US-TEVA-669860USA | TEVA | 0.00 | M | Y | 140.74000 | KG | 20160909 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126791772 | 12679177 | 1 | PS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 76565 | 75 | MG | CAPSULE | |||||||||
| 126791772 | 12679177 | 2 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 76565 | ||||||||||||
| 126791772 | 12679177 | 3 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | AS NEEDED | 0 | 1 | MG | ||||||||
| 126791772 | 12679177 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MILLIGRAM DAILY; | 0 | 1 | MG | QD | |||||||
| 126791772 | 12679177 | 5 | C | METOPROLOL ER | METOPROLOL SUCCINATE | 1 | Oral | 25 MILLIGRAM DAILY; | 0 | 25 | MG | ||||||||
| 126791772 | 12679177 | 6 | C | CARDIA | AJMALINE | 1 | 0 | ||||||||||||
| 126791772 | 12679177 | 7 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD | |||||||
| 126791772 | 12679177 | 8 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126791772 | 12679177 | 1 | Anxiety |
| 126791772 | 12679177 | 2 | Depression |
| 126791772 | 12679177 | 3 | Anxiety |
| 126791772 | 12679177 | 5 | Cardiac disorder |
| 126791772 | 12679177 | 6 | Cardiac disorder |
| 126791772 | 12679177 | 7 | Dyspepsia |
| 126791772 | 12679177 | 8 | Dysphagia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126791772 | 12679177 | Agitation | |
| 126791772 | 12679177 | Constipation | |
| 126791772 | 12679177 | Decreased appetite | |
| 126791772 | 12679177 | Dizziness | |
| 126791772 | 12679177 | Dyspnoea | |
| 126791772 | 12679177 | Headache | |
| 126791772 | 12679177 | Heart rate increased | |
| 126791772 | 12679177 | Insomnia | |
| 126791772 | 12679177 | Mood altered | |
| 126791772 | 12679177 | Palpitations | |
| 126791772 | 12679177 | Panic attack | |
| 126791772 | 12679177 | Presyncope | |
| 126791772 | 12679177 | Product substitution issue | |
| 126791772 | 12679177 | Tinnitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126791772 | 12679177 | 1 | 20160427 | 0 | ||
| 126791772 | 12679177 | 3 | 2001 | 0 | ||
| 126791772 | 12679177 | 4 | 2001 | 0 | ||
| 126791772 | 12679177 | 5 | 2001 | 0 | ||
| 126791772 | 12679177 | 6 | 2001 | 0 | ||
| 126791772 | 12679177 | 7 | 2001 | 0 |